CAR T-cell therapies: where are we now?
This recorded session from Solving Kids’ Cancer UK’s 2022 Neuroblastoma Parent Symposium explores CAR T‑cell therapy as an emerging area of research for treating neuroblastoma, particularly in cases of relapse. It offers an in‑depth look at the science behind CAR T‑cell therapy, how it is being developed for neuroblastoma, and how this cutting‑edge research compares with its use in other cancers.
Looking for something else?
-
Need to speak with someone?Get in touch with our Family Support Team.
-
Help and supportHead to our Help and Support homepage to see how we can support you.
-
Relapsed neuroblastomaFind all the information on relapsed neuroblastoma in one place.
-
Clinical trialsLearn more about clinical trials as part of treatment for neuroblastoma.
Related videos
-
VideoTreating relapsed and refractory disease
An overview of clinical trials and new treatments for relapsed and refractory neuroblastoma.
-
VideoBambino Gesù CAR T-cell trial
Explore the Bambino Gesù CAR T-cell trial in Rome and its expansion across Europe.
-
VideoCAR T-cell therapy
An introduction to CAR T‑cell therapy for neuroblastoma, including how it works and emerging research.